HEMATOLOGY LECTURE NOTES

The aim of the NMSP is to reduce morbidity and mortality associated with specific congenital metabolic disorders by screening newborns to detect the conditions before life-threatening illness or developmental delays occur. Since 1969, almost all newborns in New Zealand have been screened by the programme. ................
................

In order to avoid copyright disputes, this page is only a partial summary.